METABOLISM-CLINICAL AND EXPERIMENTAL is a premier academic journal published by W B SAUNDERS CO-ELSEVIER INC, with a distinguished history dating back to 1952. This journal serves as a vital repository of knowledge in the fields of Endocrinology, Diabetes, and Metabolism, consistently ranking in the top quartile (Q1) within these categories according to the latest metrics. With an impressive impact factor and recognized for its contributions to Biochemistry, Genetics, and Molecular Biology, it ranks #5 out of 128 in the Scopus database for Endocrinology and #11 out of 244 for Medicine related to Endocrinology, Diabetes, and Metabolism, placing it in the 95th and 96th percentiles, respectively. While the journal does not currently offer open access, it maintains rigorous peer review standards and publishes cutting-edge research that drives forward the understanding of metabolic diseases and clinical practices. By engaging with METABOLISM-CLINICAL AND EXPERIMENTAL, researchers, healthcare professionals, and students can explore groundbreaking advancements and pivotal findings that shape the future of metabolic health.

Cardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.

DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.

American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.

INTERNATIONAL JOURNAL OF OBESITY, published by SpringerNature, stands as a premier multidisciplinary platform for research in the fields of Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics, as well as Miscellaneous Medicine. With a remarkable impact, the journal is consistently positioned in the Q1 category across these critical areas, underscoring its significance in advancing the understanding of obesity and its related health outcomes. Established in 1977 and covering a broad spectrum of studies until 2024, it boasts a notable Scopus Rank reflecting its influential contributions to the scientific community, including a rank of 14 out of 140 in Nutrition and Dietetics. The INTERNATIONAL JOURNAL OF OBESITY is not just a repository of knowledge but a vital resource for researchers, clinicians, and students aiming to explore the complexities of obesity and develop evidence-based interventions. Despite not being an open-access journal, its rigorous peer-reviewed articles remain accessible to those within academic institutions, facilitating an essential dialogue among professionals dedicated to this critical global health issue.

Diabetes Metabolic Syndrome and Obesity is a leading open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing research in the fields of diabetes, metabolic syndrome, and obesity. Since its inception in 2008, the journal has aimed to disseminate high-quality, peer-reviewed articles that contribute to our understanding of these prevalent health issues, with a special focus on clinical practices, therapeutic advancements, and epidemiological studies. Boasting a commendable Q2 ranking in both Internal Medicine and Pharmacology for 2023, the journal is placed among the top tier of its category, with a Scopus ranking of #44 out of 167 in Internal Medicine and #124 out of 313 in Pharmacology. This positions the journal in the 73rd and 60th percentiles, respectively, highlighting its significance in the academic community. Researchers and professionals are encouraged to utilize this journal as a valuable resource for access to groundbreaking studies and developments in the treatment and management of diabetes and related metabolic disorders, contributing to global health improvements.

Childhood Obesity is a leading peer-reviewed academic journal published by Mary Ann Liebert, Inc., dedicated to the critical examination of obesity issues affecting children and adolescents. Covering a range of interdisciplinary research within Endocrinology, Diabetes, and Metabolism, Nutrition and Dietetics, and Pediatrics, the journal holds prestigious rankings across multiple categories, including Q1 in Pediatrics, Perinatology, and Child Health, showcasing its impact and quality in the field. With its focus on innovative research and practical solutions, Childhood Obesity invites contributions that advance understanding and strategies for combating childhood obesity, making it an invaluable resource for researchers, healthcare professionals, and students alike. Published from 2010 to 2024, the journal remains committed to enhancing public health knowledge and practices through high-quality, evidence-based studies.

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

Metabolic Syndrome and Related Disorders is an esteemed journal published by MARY ANN LIEBERT, INC, focusing on the multifaceted aspects of metabolic syndrome, including its interaction with chronic diseases such as diabetes, cardiovascular conditions, and obesity. Since its inception in 2003, this journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to advancing knowledge in the fields of endocrinology, internal medicine, and metabolic disorders. With an impact factor reflective of its academic significance, Metabolic Syndrome and Related Disorders is recognized within the Q2 and Q3 quartiles in its respective categories, solidifying its reputation among scientific and clinical communities. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and reviews that foster innovative solutions and improve patient outcomes. The journal's gradual convergence towards 2024 presents an exciting opportunity for continued exploration and dialogue about metabolic-related health challenges.

Obesity Reviews is a premier, peer-reviewed journal published by WILEY that has established itself as a leading platform in the multidisciplinary fields of endocrinology, public health, and obesity research since its inception in 2000. With an impressive Q1 ranking in both Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health, this journal provides a significant contribution to understanding the complexity of obesity and its associated health implications. The journal features comprehensive reviews and original research that illuminate the underlying mechanisms, public health challenges, and innovative interventions related to obesity. With a strong commitment to advancing knowledge and research, Obesity Reviews continues to attract high-impact studies, as evidenced by its top-tier Scopus rankings—placing it in the 98th and 96th percentiles within its fields. The journal is based in the United Kingdom and serves as a vital resource for researchers, professionals, and students dedicated to combating obesity and improving health outcomes worldwide.